Approval · Notice of Compliance 35253 · 2025
TEPEZZA: Notice of Compliance 35253
Issued April 17, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35253
- Date
- April 17, 2025
- Company
- Amgen Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEPEZZA | 02557061 | Marketed |
Medicinal ingredients
- TEPROTUMUMAB 500 MG per VIAL